GlobeNewsWire
04 Aug 2026, 03:05 UTC · 10w ago
KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders
Impact · against what's priced in
The announcement of investigations into potential fiduciary duty breaches by the boards of Kalaris Therapeutics and SDEV introduces governance and legal risk. These developments act as negative catalysts by creating potential liability and institutional uncertainty for both companies.
- KLRS−0.30
No priced-in read yet





